| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 62.50 | 0.53 (+0.86%) | 53.25 - 64.87 | 1.4 million |
Market data as of 4:03PM 05/24/13. Quotes are delayed by at least 15 min.
| Open | 61.54 |
|---|---|
| Previous Close | 61.97 |
| Day's Range | 61.44 - 62.56 |
| Market Cap | 9.9B |
| Avg Volume (10 Day) | 1.3M |
| Price/Earnings (Trailing 12 Mo.) | 18.8x |
| Earnings Per Share (Trailing 12 Mo.) | 3.32 |
| Dividend Yield | 0.30 (1.92%) |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Pass |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Pass |
| Shareholder's money handled rationally? | Pass |
| Increased shareholder value? | Fail |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Pass |
|---|---|
| Room to increase dividends? | Pass |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Fail |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
Quest Diagnostics Declares Quarterly Cash Dividend
PR Newswire - Tuesday 05/21/2013 2:16 PM ET
Quest Diagnostics Acquires Concentra's Laboratory Business, Enters into Exclusive Services Agreement
PR Newswire - Thursday 05/16/2013 10:08 AM ET
Decades of Improving Cholesterol Levels Abruptly Ended in 2008, PLOS ONE Study Finds
PR Newswire - Monday 05/13/2013 2:58 PM ET
Quest Diagnostics to Speak at the Bank of America Merrill Lynch 2013 Health Care Conference
PR Newswire - Tuesday 05/07/2013 10:13 AM ET
| DGX | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -5.15% | |
| Net Income Growth (1yr) | -21.31% | |
| Total Debt/Equity | 0.81 | |
| LT Debt/Equity | 0.75 | |
| Earnings Yield | 5.32% | |
| Price/Sales | 1.37 |
| Company | Last | Change |
|---|---|---|
| Laboratory Corporation of America Holdings | 100.37 | -0.34% |
| Life Technologies Corp | 74.04 | +0.14% |
| Mettler-Toledo International Inc | 221.97 | -0.04% |
| Covance Inc | 76.67 | +0.20% |
| Agilent Technologies Inc | 45.59 | -0.33% |
Data is delayed by at least 15 min.